All India Institute of Medical Sciences, Jodhpur, India.
Anaesthesiol Intensive Ther. 2021;53(5):418-428. doi: 10.5114/ait.2021.111594.
Tracheostomy is a standard surgical procedure that is used in critically ill patients who require sustained mechanical ventilation. In this article, we review the outcomes of coronavirus disease 2019 (COVID-19) patients who underwent tracheostomy. We searched for relevant articles on PubMed, Scopus, and Google Scholar, up to April 20, 2021. This meta- analysis examines ventilation liberation, decannulation, and hospital mortality rates in COVID-19 patients who have undergone tracheostomy. Two investigators evaluated the articles, and the differences of opinion were settled by consensus with a third author. A total of 4366 patients were included in 47 related articles for this meta-analysis. After data pooling, the proportions of ventilation liberation, decannulation and mortality were found to be 48% (95% CI: 31-64), 42% (95% CI: 17-69) and 18% (95% CI: 9-28) respectively. The Luis Furuya-Kanamori (LFK) index values for ventilation liberation, decannulation and mortality were 4.28, 1.32 and 0.69. No transmission of the disease attributable to participating in tracheostomy procedures was reported in most of the included articles.
气管切开术是一种标准的外科手术，用于需要持续机械通气的危重症患者。本文回顾了接受气管切开术的 2019 冠状病毒病（COVID-19）患者的结局。我们在 PubMed、Scopus 和 Google Scholar 上搜索了截至 2021 年 4 月 20 日的相关文章。这项荟萃分析检查了 COVID-19 患者接受气管切开术的通气撤离、拔管和住院死亡率。两名调查员评估了这些文章，意见分歧通过第三名作者的共识解决。共有 47 篇相关文章纳入了 4366 例患者进行荟萃分析。数据汇总后，通气撤离、拔管和死亡率的比例分别为 48%（95%CI：31-64）、42%（95%CI：17-69）和 18%（95%CI：9-28）。通气撤离、拔管和死亡率的 Luis Furuya-Kanamori（LFK）指数值分别为 4.28、1.32 和 0.69。在大多数纳入的文章中，没有报告与参与气管切开术相关的疾病传播。
